Tandem Diabetes Care Announces FDA Clearance of t:connect Diabetes Management Application for Use with t:slim Insulin Pump
Their press release: http://www.tandemdiabetes.com/Content1Col.aspx?id=748
Tandem Diabetes Care Acquires Select Patents and Patent Applications from Smiths Medical
SAN DIEGO, Feb. 1, 2013 /PRNewswire/ -- Tandem Diabetes Care, Inc. ("Tandem") announced today that it has acquired ownership from Smiths Medical ASD, Inc. of over 23 U.S. patents and patent applications relating to the treatment of diabetes. As part of this transaction, Tandem has also obtained a license to 28 other U.S. patents and patent applications owned by Smiths Medical. This license affords Tandem exclusive access to technologies useful for future product development in the field of ambulatory infusion pumps and related software and accessories for the treatment of diabetes. These patents and patent applications complement Tandem's growing portfolio of intellectual property related to the company's novel technologies PR Newswire (http://s.tt/1zfjY)
SAN DIEGO, Jan. 8, 2013 /PRNewswire via COMTEX/ -- Tandem Diabetes Care, Inc. ("Tandem") announced today a partnership with JDRF, the leading global organization focused on type 1 diabetes (T1D) research, to develop a first-of-its-kind, dual-chamber infusion pump for the management of diabetes. The partnership agreement is designed to accelerate the development of a next-generation, fully automated artificial pancreas system using therapies in conjunction with insulin.Looks a lot like a JDRF IDDP. Has all the right words, performance based milestones etc, just not the IDDP letter. Full test here:
Your Diabetes May Vary
© 2007 - 2015